Who Buys Rifampicin from India — 780 Importers Behind a $1.3B Market
India's rifampicin import market is served by 780 active buyers who collectively imported $1.3B across 3,913 shipments. CAMESKIN/CORDAID (CONGO DR) leads with a 39.5% market share, followed by NATIONAL TUBERCULOSIS AND LEPROSY and LA PHARMACIE CENTRALE DE TUNISIE. The top 5 buyers together control 79.7% of total import value, reflecting a concentrated buyer landscape.
Top Rifampicin Importers — Ranked by Import Value
CAMESKIN/CORDAID (CONGO DR) is the leading rifampicin importer from India, holding a 39.5% share of the $1.3B market across 3,913 shipments from 780 buyers. The top 5 buyers — CAMESKIN/CORDAID (CONGO DR), NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA), LA PHARMACIE CENTRALE DE TUNISIE (TUNISIA), DIRECTOR MBDC DGHS (BANGLADESH), SECRETARY FOR HEALTH AND CHILD CARE (ZIMBABWE) — collectively control 79.7% of total import value.
Top Rifampicin Buyers & Importers
Ranked by import value · 780 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | CAMESKIN/CORDAIDCONGO DR | $532.5M | 5 | 39.5% |
| 2 | NATIONAL TUBERCULOSIS AND LEPROSYNIGERIA RIFAMPICIN 150MG / ISONIAZID 75MG TABLETS.RIFAMPICIN CAPSULES BP 150MG.RIFAMPICIN 150MG +ISONIAZID 75MG TABLETS | $248.7M | 5 | 18.4% |
| 3 | LA PHARMACIE CENTRALE DE TUNISIETUNISIA RIFAMPICIN 150MG / ISONIAZID 75MG TABLETS.4 FDC 24X28T GDF RIFAMPICIN, ISONIAZID,RIFAMPICIN 150MG +ISONIAZID 75MG TABLETS | $144.9M | 5 | 10.7% |
| 4 | DIRECTOR MBDC DGHSBANGLADESH RIFAMPICIN 150MG / ISONIAZID 75MG TABLETS.RIFAMPICIN CAPSULES BP 150MG.RIFAMPICIN 150MG +ISONIAZID 75MG TABLETS | $88.9M | 5 | 6.6% |
| 5 | SECRETARY FOR HEALTH AND CHILD CAREZIMBABWE RIFAMPICIN 150MG / ISONIAZID 75MG TABLETS.RIFAMPICIN 75MG / ISONIAZID 50MG DISPERSIBLE TABLETS. | $60.4M | 5 | 4.5% |
| 6 | NATIONAL PROGRAMME FOR TBSRI LANKA RIFAMPICIN 150MG / ISONIAZID 75MG TABLETS.RIFAMPICIN CAPSULES BP 150MG.RIFAMPICIN 150MG +ISONIAZID 75MG TABLETS | $21.8M | 5 | 1.6% |
| 7 | MINISTERIO DE SALUD PUBLICA YGUATEMALA PHARMA : 2 FDC TABLETS PAHO - 1BOX X 24X28 TABS | $20.8M | 5 | 1.5% |
| 8 | CLINICAL RESEARCH PRODUCTUNITED STATES RIFAMPIN CAPSULES 300MG - 1BTLX60 CAPSPHARMA : RIFAMPIN CAPSULES 300MG - 1BTLX30 CAPS | $16.8M | 5 | 1.2% |
| 9 | NATIONAL DRUG SERVICE ORGANISATIONLESOTHO RIFAMPICIN 150MG / ISONIAZID 75MG TABLETS.RIFAMPICIN CAPSULES BP 150MG.RIFAMPICIN 150MG +ISONIAZID 75MG TABLETS | $10.5M | 5 | 0.8% |
| 10 | MINISTRY OF HEALTH OF THE REPUBLICZAMBIA RIFAMPICIN 150MG / ISONIAZID 75MG TABLETS.RIFAMPICIN 150MG+ISONIAZID 75MG+PYRAZINAMEDICINES. RIFAMPICIN 150MG+ISONIAZID 75 | $10.4M | 5 | 0.8% |
| 11 | PHARMACIE CENTRALE DES HOPITAUX,ALGERIA RIFAMPICIN 75MG AND ISONIAZID 50MG DISPE | $7.9M | 5 | 0.6% |
| 12 | I+SOLUTIONSNETHERLANDS 4 FDC 24X28T GDF RIFAMPICIN, ISONIAZID, | $6.6M | 5 | 0.5% |
| 13 | MINISTERIO DA SAUDE/DEPARTAMENTO DEBRAZIL PHARMA : 2 FDC TABLETS PAHO - 1BOX X 24X28 TABS | $4.6M | 5 | 0.3% |
| 14 | WORLD HEALTH ORGANIZATION (BANGLADEBANGLADESH RIFAMPICIN 150MG / ISONIAZID 75MG TABLETS.RIFAMPICIN 150MG +ISONIAZID 75MG TABLETS | $4.6M | 5 | 0.3% |
| 15 | MACLEODS PHARMACEUTICALS SASOUTH AFRICA RIFAMPICIN 150MG+ISONIAZID 75MG+PYRAZINAMEDICINES. RIFAMPICIN 150MG+ISONIAZID 75MEDICINES. RIFAMPICIN 300MG+ISONIAZID 15 | $4.5M | 5 | 0.3% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Rifampicin — and from which countries?
Flow of Rifampicin exports from India: each country's share and the named importers behind the numbers
Rifampicin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Congo Dr
Congo Dr emerges as the first largest importing country, achieving a total trade value of $536.0M through 6 shipments. This represents a market share of 39.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Congo Dr has a diverse importer base, with their top importers including:
• CAMESKIN/CORDAID - $532.5M (99.3% of country's total business)
Key Insight: Congo Dr demonstrates strong market positioning with an average shipment value of $89.3M, indicating premium pricing strategy compared to the market average of $344.9K.
Congo Dr is a key market for Rifampicin imports, representing 39.7% of total trade value.
2Nigeria
Nigeria emerges as the second largest importing country, achieving a total trade value of $252.7M through 67 shipments. This represents a market share of 18.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• NATIONAL TUBERCULOSIS AND LEPROSY - $248.7M (98.4% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $3.8M, indicating premium pricing strategy compared to the market average of $344.9K.
Nigeria is a key market for Rifampicin imports, representing 18.7% of total trade value.
3Tunisia
Tunisia emerges as the third largest importing country, achieving a total trade value of $145.1M through 16 shipments. This represents a market share of 10.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Tunisia has a diverse importer base, with their top importers including:
• LA PHARMACIE CENTRALE DE TUNISIE - $144.9M (99.9% of country's total business)
Key Insight: Tunisia demonstrates strong market positioning with an average shipment value of $9.1M, indicating premium pricing strategy compared to the market average of $344.9K.
Tunisia is a key market for Rifampicin imports, representing 10.7% of total trade value.
4Bangladesh
Bangladesh emerges as the fourth largest importing country, achieving a total trade value of $96.2M through 22 shipments. This represents a market share of 7.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Bangladesh has a diverse importer base, with their top importers including:
• DIRECTOR MBDC DGHS - $88.9M (92.4% of country's total business)
• WORLD HEALTH ORGANIZATION (BANGLADE - $4.6M (4.8% of country's total business)
Key Insight: Bangladesh demonstrates strong market positioning with an average shipment value of $4.4M, indicating premium pricing strategy compared to the market average of $344.9K.
Bangladesh is a key market for Rifampicin imports, representing 7.1% of total trade value.
5Zimbabwe
Zimbabwe emerges as the fifth largest importing country, achieving a total trade value of $60.7M through 4 shipments. This represents a market share of 4.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Zimbabwe has a diverse importer base, with their top importers including:
• SECRETARY FOR HEALTH AND CHILD CARE - $60.4M (99.4% of country's total business)
Key Insight: Zimbabwe demonstrates strong market positioning with an average shipment value of $15.2M, indicating premium pricing strategy compared to the market average of $344.9K.
Zimbabwe is a key market for Rifampicin imports, representing 4.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Rifampicin buyer market intelligence
1Buyer Segment Analysis
The importation of Rifampicin from India involves various buyer segments, each with distinct procurement behaviors:
- Government Procurement Agencies: Entities such as CAMESKIN/CORDAID (Democratic Republic of Congo), NATIONAL TUBERCULOSIS AND LEPROSY (Nigeria), LA PHARMACIE CENTRALE DE TUNISIE (Tunisia), DIRECTOR MBDC DGHS (Bangladesh), SECRETARY FOR HEALTH AND CHILD CARE (Zimbabwe), NATIONAL PROGRAMME FOR TB (Sri Lanka), MINISTERIO DE SALUD PUBLICA Y (Guatemala), NATIONAL DRUG SERVICE ORGANISATION (Lesotho), and MINISTRY OF HEALTH OF THE REPUBLIC (Zambia) fall into this category. These organizations typically engage in large-scale, tender-based purchasing to supply national healthcare programs, ensuring consistent and cost-effective access to essential medicines. Their procurement cycles are often annual or bi-annual, aligning with budget allocations and public health initiatives.
- Clinical Research Organizations: An example is CLINICAL RESEARCH PRODUCT (United States). These entities procure Rifampicin for clinical trials and research purposes. Their purchasing patterns are project-specific, with volumes and frequencies varying based on study requirements and timelines.
Understanding these segments is crucial for suppliers aiming to tailor their offerings and engagement strategies to meet the specific needs and procurement behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Rifampicin buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Rifampicin from India, the import regulations are as follows:
1. Democratic Republic of Congo (DRC):
2. Nigeria:
3. Tunisia:
4. Bangladesh:
5. Zimbabwe:
Navigating these regulatory landscapes requires thorough preparation and adherence to each country's specific requirements to ensure successful market entry and sustained supply chain operations.
Demand Drivers & Market Opportunity
TransData Nexus Rifampicin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Rifampicin in importing countries is primarily driven by several key factors:
- Disease Prevalence: Tuberculosis (TB) remains a significant public health challenge globally. According to the World Health Organization (WHO), in 2022, approximately 10.6 million people fell ill with TB worldwide, underscoring the ongoing need for effective treatments like Rifampicin.
- Government Healthcare Programs: Many countries have implemented national TB control programs aimed at reducing the incidence and mortality associated with the disease. These programs often include the procurement and distribution of essential medicines, including Rifampicin, to ensure widespread access to treatment.
- Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased investment in healthcare infrastructure and services, facilitating better diagnosis and treatment of TB and other infectious diseases. This expansion enhances the accessibility of medications like Rifampicin to broader populations.
- WHO Essential Medicines List Procurement: Rifampicin is listed on the WHO Model List of Essential Medicines, guiding countries in prioritizing its procurement to address critical health needs. This inclusion reinforces its importance in national healthcare systems and supports consistent demand.
- Tender-Based Purchasing: Many governments and international organizations utilize tender systems to procure pharmaceuticals, ensuring cost-effectiveness and quality. The repeat buyer rate of 67.9% among the 780 buyers across 162 countries indicates a stable and ongoing demand for Rifampicin, reflecting its critical role in TB treatment protocols.
These factors collectively contribute to a robust market opportunity for Rifampicin, emphasizing the importance of sustained production and supply to meet global health demands.
Common Questions — Rifampicin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest rifampicin buyer importing from India?
Based on import volume and value, CAMESKIN/CORDAID (CONGO DR) leads with $532.5M in imports and a 39.5% market share — the highest of any single rifampicin importer. NATIONAL TUBERCULOSIS AND LEPROSY (NIGERIA) and LA PHARMACIE CENTRALE DE TUNISIE (TUNISIA) are the next largest buyers.
QHow many companies buy rifampicin from India?
There are 780 active rifampicin buyers importing from India, with a combined market of $1.3B across 3,913 shipments to 162 countries. The top 5 buyers hold 79.7% of total import value, while the remaining 775 buyers handle the other 20.3%.
QWhich countries import the most rifampicin from India?
The top importing countries for rifampicin from India are Congo Dr (39.7%), Nigeria (18.7%), Tunisia (10.7%), Bangladesh (7.1%), Zimbabwe (4.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of rifampicin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for rifampicin from India?
The average import transaction value for rifampicin from India is $344.9K, with an average unit price of $6.47 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Rifampicin buyer market intelligence
1Buyer Segment Analysis
The importation of Rifampicin from India involves various buyer segments, each with distinct procurement behaviors:
- Government Procurement Agencies: Entities such as CAMESKIN/CORDAID (Democratic Republic of Congo), NATIONAL TUBERCULOSIS AND LEPROSY (Nigeria), LA PHARMACIE CENTRALE DE TUNISIE (Tunisia), DIRECTOR MBDC DGHS (Bangladesh), SECRETARY FOR HEALTH AND CHILD CARE (Zimbabwe), NATIONAL PROGRAMME FOR TB (Sri Lanka), MINISTERIO DE SALUD PUBLICA Y (Guatemala), NATIONAL DRUG SERVICE ORGANISATION (Lesotho), and MINISTRY OF HEALTH OF THE REPUBLIC (Zambia) fall into this category. These organizations typically engage in large-scale, tender-based purchasing to supply national healthcare programs, ensuring consistent and cost-effective access to essential medicines. Their procurement cycles are often annual or bi-annual, aligning with budget allocations and public health initiatives.
- Clinical Research Organizations: An example is CLINICAL RESEARCH PRODUCT (United States). These entities procure Rifampicin for clinical trials and research purposes. Their purchasing patterns are project-specific, with volumes and frequencies varying based on study requirements and timelines.
Understanding these segments is crucial for suppliers aiming to tailor their offerings and engagement strategies to meet the specific needs and procurement behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Rifampicin buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Rifampicin from India, the import regulations are as follows:
1. Democratic Republic of Congo (DRC):
2. Nigeria:
3. Tunisia:
4. Bangladesh:
5. Zimbabwe:
Navigating these regulatory landscapes requires thorough preparation and adherence to each country's specific requirements to ensure successful market entry and sustained supply chain operations.
Demand Drivers & Market Opportunity
TransData Nexus Rifampicin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Rifampicin in importing countries is primarily driven by several key factors:
- Disease Prevalence: Tuberculosis (TB) remains a significant public health challenge globally. According to the World Health Organization (WHO), in 2022, approximately 10.6 million people fell ill with TB worldwide, underscoring the ongoing need for effective treatments like Rifampicin.
- Government Healthcare Programs: Many countries have implemented national TB control programs aimed at reducing the incidence and mortality associated with the disease. These programs often include the procurement and distribution of essential medicines, including Rifampicin, to ensure widespread access to treatment.
- Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased investment in healthcare infrastructure and services, facilitating better diagnosis and treatment of TB and other infectious diseases. This expansion enhances the accessibility of medications like Rifampicin to broader populations.
- WHO Essential Medicines List Procurement: Rifampicin is listed on the WHO Model List of Essential Medicines, guiding countries in prioritizing its procurement to address critical health needs. This inclusion reinforces its importance in national healthcare systems and supports consistent demand.
- Tender-Based Purchasing: Many governments and international organizations utilize tender systems to procure pharmaceuticals, ensuring cost-effectiveness and quality. The repeat buyer rate of 67.9% among the 780 buyers across 162 countries indicates a stable and ongoing demand for Rifampicin, reflecting its critical role in TB treatment protocols.
These factors collectively contribute to a robust market opportunity for Rifampicin, emphasizing the importance of sustained production and supply to meet global health demands.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 780 global importers of Rifampicin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,913 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 162 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,913 Verified Shipments
780 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists